Tag Archives: Fiorello Pharmaceuticals

Here Are the 5 New Licensees for the New York Medical Marijuana Program

Here Are the 5 New Licensees for the New York Medical Marijuana Program

Here Are the 5 New Licensees for the New York Medical Marijuana Program

On Aug. 1, 2017, the NYSDOH announced that it had approved five more registered organizations for the New York Medical Marijuana Program, with each registered organization permitted to cultivate and dispense medical marijuana in the state.

NYSDOH regulations Announces Chronic Pain to Be Added As Qualifying Condition for Medical Marijuana Enhancements, New Registered Organizations

New York State Department of Health Adds Five New Registered Organizations to Medical Marijuana Program

ALBANY, N.Y., Aug. 1, 2017 /Weed Wire/ – The New York State Department of Health today announced that it has authorized five additional registered organizations (ROs) to manufacture and dispense medical marijuana in New York State, an initiative aimed at improving patient access and the geographic distribution of dispensing facilities across the state.

Fiorello Pharmaceuticals

Fiorello Pharmaceuticals Awarded Registered Organization Status for New York State Medical Marijuana Program

NEW YORK, Aug. 1, 2017 /Weed Wire/ — Fiorello Pharmaceuticals, Inc., a pharmaceutical company focused on aiding patients with significant, painful and life-threatening conditions, is proud to announce that it has been selected as a Registered Organization in the expansion of New York State’s Medical Marijuana Program.


Top